This from The BULL weekly share tips (free)
This respiratory care products provider has been on a five year run, but has struggled technically around $13. The market has high growth expectations, with FPH recently trading on an estimated 2018 price/earnings multiple of 42 times. The risk is to the downside, as any slip up will be punished.